Manufacturer record
Nikvin Healthcare (I) Pvt Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Nikvin Healthcare (I) Pvt Ltd (Himachal Pradesh) were declared Not of Standard Quality between December 2019 and April 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Nikvin Healthcare (I) Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amoxycillin and potassium clavulanate tablets IP (AUGMONT CV 625 DUP Co- amoxiclav) | BT408244AMfg 2024-08 · Exp 2026-04 | Sample does not conform to IP specification for amoxycillin and potassium clavulanate tablets with respect to the content of Clavulanic acid in potassium clavulanate.Other | DTL MaduraiState lab | Apr 2025 |
| Amoxycillin & Potassium Calvulanate Tablets | BT406210AMfg 2024-06 · Exp 2026-05 | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate Tablets with respect to Dissolution for Clavulanic Acid and to the content of Clavulanic Acid in Potassium Clavulanate DilutedDissolution | DTL ChennaiState lab | Apr 2025 |
| Cefuroxime Axetil Tablets I.P. 500mg. (Amytum-500) | C903701TMfg 2019-03 · Exp 2021-02 | DissolutionDissolution | RDTL GuwahatiState lab | Dec 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.